BEDFORD, Mass. (AP) - BEDFORD, Mass. (AP) - Homology Medicines Inc. (FIXX) on Tuesday reported a loss of $33 million in its third quarter. The Bedford, Massachusetts-based company said it had a loss of 57 cents per share. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX
Homology is a Massachusetts-based clinical-stage genetic medicine company that develops and commercializes novel therapies for the treatment of genetic diseases.